Loading company…
SHENDE develops MRI-guided focused ultrasound equipment for non-invasive diagnosis and treatment.
Founded in 2013 and based in Shanghai, SHENDE develops ultrasound equipment for non-invasive tumor ablation. Its products include systems for breast adenoma diagnosis and treatment, bone tumor pain relief, Parkinson's disease, and brain tumors. In October 2023, it raised approximately CNY 200 million in Series D funding from Hefei State-Owned Assets Holding, Ningbo Dading Shengye Investment Management, Zhongli Capital, and an individual investor.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in